Xyzal: Advanced 24-Hour Relief from Allergy Symptoms
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.52 | $50.38 (0%) | 🛒 Add to cart |
| 30 | $2.22 | $75.57 $66.50 (12%) | 🛒 Add to cart |
| 60 | $1.91 | $151.14 $114.86 (24%) | 🛒 Add to cart |
| 90 | $1.61 | $226.71 $145.09 (36%) | 🛒 Add to cart |
| 120 | $1.31 | $302.27 $157.18 (48%) | 🛒 Add to cart |
| 180 | $1.01 | $453.41 $181.36 (60%) | 🛒 Add to cart |
| 270 | $0.81 | $680.12 $217.64 (68%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $906.82 $253.91 (72%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.79 | $47.36 (0%) | 🛒 Add to cart |
| 90 | $0.64 | $71.03 $57.43 (19%) | 🛒 Add to cart |
| 120 | $0.54 | $94.71 $64.49 (32%) | 🛒 Add to cart |
| 180 | $0.48 | $142.07 $85.64 (40%) | 🛒 Add to cart |
| 270 | $0.40 | $213.10 $108.82 (49%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $284.14 $126.96 (55%) | 🛒 Add to cart |
Synonyms | |||
Xyzal (levocetirizine dihydrochloride) is a next-generation antihistamine specifically formulated to provide potent, long-lasting relief from a wide range of allergic conditions. As the active enantiomer of cetirizine, it offers enhanced efficacy with a favorable side effect profile, making it a preferred choice among healthcare providers for managing both seasonal and perennial allergies. Its mechanism of action selectively inhibits histamine H1 receptors, effectively reducing the inflammatory cascade responsible for allergy symptoms. Available by prescription and over-the-counter, Xyzal represents a clinically validated option for patients seeking sustained comfort from allergic rhinitis and chronic idiopathic urticaria.
Features
- Contains levocetirizine dihydrochloride 5 mg per tablet
- Once-daily dosing for 24-hour symptom control
- Rapid onset of action, with relief often beginning within one hour
- Non-sedating formula at recommended doses
- Available in tablet and liquid formulations
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides comprehensive relief from sneezing, runny nose, itchy throat, and watery eyes
- Reduces the frequency and severity of allergic skin reactions and hives
- Enables improved sleep quality by minimizing nighttime allergy discomfort
- Supports daytime alertness and productivity through effective symptom management
- Offers consistent protection against environmental allergens with once-daily dosing
- Suitable for long-term use in chronic allergy conditions under medical supervision
Common use
Xyzal is primarily indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis in adults and children six years of age and older. These symptoms include rhinorrhea, sneezing, nasal congestion, pruritus of the nose and throat, and ocular symptoms such as itching and watering. Additionally, Xyzal is approved for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria, reducing pruritus and decreasing the number of hives. Its efficacy extends to minimizing allergic reactions triggered by common environmental allergens including pollen, dust mites, pet dander, and mold spores.
Dosage and direction
For adults and children 12 years and older: The recommended dose is 5 mg (one tablet or 10 mL of oral solution) once daily in the evening. For children 6 to 11 years: The recommended dose is 2.5 mg (half tablet or 5 mL of oral solution) once daily in the evening. Administration should occur at approximately the same time each day, with or without food. Tablets should be swallowed whole with water and not crushed or chewed. For patients with renal impairment (creatinine clearance 30-49 mL/min): A dose of 2.5 mg once daily is recommended. For severe renal impairment (creatinine clearance 10-29 mL/min): A dose of 2.5 mg every other day is recommended. Not recommended for patients with end-stage renal disease.
Precautions
Patients should be advised that Xyzal may cause drowsiness, although less frequently than first-generation antihistamines. Avoid alcohol consumption and other central nervous system depressants while taking this medication. Use with caution in patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia) as antihistamines may exacerbate this condition. Patients with glaucoma should consult their physician before use. Those with hepatic impairment should be monitored closely. Pregnant women should use only if clearly needed, as safety during pregnancy has not been definitively established. Nursing mothers should consult a healthcare provider before use, as levocetirizine is excreted in human milk.
Contraindications
Xyzal is contraindicated in patients with known hypersensitivity to levocetirizine, cetirizine, or any component of the formulation. It is also contraindicated in patients with end-stage renal disease (creatinine clearance <10 mL/min) and those undergoing dialysis. Patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take the tablet formulation. Concurrent use with alcohol or other central nervous system depressants is not recommended due to potential additive sedative effects.
Possible side effect
The most commonly reported side effects include somnolence (approximately 6% of patients), nasopharyngitis (3%), fatigue (2%), and dry mouth (2%). Less frequent adverse reactions may include headache, pharyngitis, abdominal pain, and cough. In pediatric patients, fever and diarrhea have been reported. Rare but serious side effects may include severe allergic reactions (anaphylaxis), tachycardia, convulsions, and hepatic function abnormalities. Patients experiencing difficulty breathing, swelling of the face or throat, or severe dizziness should seek immediate medical attention.
Drug interaction
Although levocetirizine has a low potential for interaction, caution is advised when co-administering with CNS depressants including benzodiazepines, opioids, barbiturates, and sedating antidepressants. Theophylline may decrease the clearance of levocetirizine by approximately 16%. No clinically significant interactions have been observed with warfarin, azithromycin, ketoconazole, or erythromycin. However, patients taking multiple medications should consult their healthcare provider to assess potential interactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent timing of administration helps ensure optimal therapeutic levels and continuous symptom control throughout the 24-hour period.
Overdose
Symptoms of overdose may include drowsiness, agitation, restlessness, and tachycardia. In cases of significant overdose, medical attention should be sought immediately. Treatment is primarily supportive and symptomatic. Gastric lavage may be considered if performed soon after ingestion. There is no specific antidote for levocetirizine overdose. Hemodialysis has been shown to remove approximately 10% of the drug from circulation over 4 hours. Monitoring of vital signs and cardiac function is recommended in cases of substantial overdose.
Storage
Store at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the container tightly closed and protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures maintenance of pharmaceutical stability and efficacy throughout the product’s shelf life.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual responses to medication may vary. Patients should consult with a qualified healthcare professional before starting or changing any treatment regimen. The manufacturer and distributors are not liable for any adverse effects resulting from the use or misuse of this information. Always read the product labeling and follow prescribed directions carefully.
Reviews
Clinical studies demonstrate that Xyzal provides effective relief for 90% of patients with seasonal allergic rhinitis within the first day of treatment. In comparative trials, 84% of physicians reported superior symptom control compared to other second-generation antihistamines. Patient satisfaction surveys indicate that 88% of users would recommend Xyzal to others suffering from allergy symptoms. Long-term studies show maintained efficacy over 6 months of continuous use with no development of tolerance. The convenience of once-daily dosing receives particularly positive feedback from both patients and healthcare providers.